Liege 2019 – Radiopharmacy Programme

 

Saturday, May 11

 

FANC/AFCN: Application submitted

WELCOME

Common to all attendees

Location: Grand foyer

8:40-8:50  

WELCOME BY BELNUC PRESIDENT

Pieter De Bondt

OLV Ziekenhuis Aalst, Belgium

COMMON OPENING SESSION

Medical, radiopharmacy and physics common session

Location: Auditorium Reine Elisabeth

9:00-10:30 OPPORTUNITIES FOR PATIENT CARE
Chaired by Prof Guy Bormans, Prof Michel Koole and Prof Dr Patrick Flamen
9:00-9:30 Developments in total body PET/CT systems

Prof Dr Stefaan Vandenberghe

MEDISIP-ELIS-IBITECH-IMEC, Ghent University, Belgium

9:30-10:00 PSMA targeted radioligand therapy in prostate cancer: Towards the future.

Dr Andrei Gafita

Department of Nuclear Medicine, Klinikum rechts der Isar, Technical University of Munich, Germany

10:00-10:30 Holmium-166 Radioembolization

Prof Dr M.G.E.H. (Marnix) Lam

Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, The Netherlands

COFFEE BREAK

10:30-11:00

Location: Grand foyer

RADIOCHEMISTRY

Radiopharmacy and radiochemistry session

Location: Mosane 5

RadioChemistry
Chaired by Filip de Vos
11:00-11:05 Welcome Radiopharmacy session

Filip de Vos, UGhent, Ghent, Belgium

Zéna Wimana, Nuclear Medicine Department, Institut Jules Bordet, Brussels, Belgium

11:05-11:25 Flow chemistry and chemometrics: an innovative way to optimize the radiopharmaceutical R&D

Mallory Salvé

Nuclear Medicine and Oncological Imaging Division, CHU of Liege, Liège,Belgium

GIGA-CRC In VIVO Imaging, University of Liège, Liège, Belgium

11:25: 12:10 Gallium-68 produced by cyclotron vs generator: pros and cons

Simon Lacroix, Nuclear Medicine Department, Hôpital Erasme, Brussels, Belgium

Zéna Wimana, Nuclear Medicine Department, Institut Jules Bordet, Brussels, Belgium

LUNCH &

MEET THE SPONSORS

12:10-14:00

Location: Grand foyer

POSTER SESSION

Location: Grand foyer

12:10-12:50 MEET THE AUTHOR

BAYER SPONSORED SYMPOSIUM

Location: Auditorium 250

13:10-13-55 SATURDAY NOON LECTURE ON RADIUM-223

TARGET

Radiopharmacy and radiochemistry session

Location: Mosane 5

Chaired by Vicky Caveliers
14:00-14:30 How to investigate the radiobiological effects of radionuclide therapies: Models, techniques  and tools

Sarah Baatout

Radiobiology unit, SCK•CEN, Mol, Belgium

 

14:30-15:30 SCIENTIFIC ABSTRACTS
14:30-14:42 Labeling of an anti-HER2 nanobody with the α-particle emitter bismuth-213: in vitro and in vivo evaluation

Yana Dekempeneer

Institute for Nuclear Materials Science, Belgian Nuclear Research Center (SCK•CEN), Mol, Belgium

In vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel (VUB), Brussels, Belgium

14:42-14:54 Understanding the radiobiology of targeted radionuclide therapy with 177Lu-DOTATATE

Wendy Delbart

Nuclear Medicine Department, Jules Bordet Institute, Université Libre de Bruxelles, Belgium

14:54-15:06 Development and evaluation of selective PET probes for imaging of caspase-3 activity

Lucas Beroske

Molecular Imaging Center Antwerp, University of Antwerp, Wilrijk, Belgium

Department of Nuclear Medicine, Antwerp University Hospital, Antwerp, Belgium

15:06-15:18 Comparison of [68Ga]PSMA-11 and [18F]PSMA-11 for in vivo PET/CT imaging of prostate cancer

Sarah Piron

Ghent University, Lab Radiopharmacy, Ghent, Belgium

15:18-15:30 Discrimination between glioblastoma and radionecrosis using preclinical [18F]FET, 2-[18F]FELP and [18F]FDG PET in rats

Jeroen Verhoeven

Laboratory of Radiopharmacy, Ghent University, Belgium

COFFEE BREAK

15:30-16:00

Location: Grand foyer

Radiopharmacy GMP/Regulations

Radiopharmacy and radiochemistry session

Location: Mosane 5

Radiopharmacy GMP/Regulations
Chaired by  Dominique Vanderghinste
16:00-16:25 Pharmaceutical Quality System

Kim Serdons

Nuclear Medicine Department, UZ Leuven, Leuven, Belgium

16:25-16:55 GMP: update and changes in Annex 1

Julie Cousaert

Nuclear Medicine Department, UZ Brussel, Brussel, Belgium

COMMON CLOSING SESSION

Medical, radiopharmacy and physics common session

Location: Auditorium Reine Elisabeth

17:00-17:30 RADIONUCLIDE THERAPY
Chaired by Dr Marcel Stokkel and Sarah Baatout
17:00-17:30 Radiolabeled Nanobodies for targeted α-particle therapy

Prof Matthias D’Huyvetter

In Vivo Cellular and Molecular Imaging Laboratory, Vrije Universiteit Brussel, Belgium

2019 BELNUC AWARDS CEREMONY

Common session

Location: Auditorium Reine Elisabeth

17:30-18:00 BELNUC AWARD CEREMONY
2019 BELNUC AWARD
2019 YOUNG NUCLEARIST AWARD
2019 BEST ORAL PRESENTATION IN RADIOPHARMACY & RADIOCHEMISTRY
2019 BEST ORAL PRESENTATION IN PHYSICS & ENGINEERING
2019 TECHNOLOGIST SECTION AWARD